Europe • Frankfurt Stock Exchange • FRA:IX1 • US45168D1046
The current stock price of IX1.DE is 539.6 EUR. In the past month the price decreased by -10.6%. In the past year, price increased by 34.1%.
ChartMill assigns a technical rating of 8 / 10 to IX1.DE. When comparing the yearly performance of all stocks, IX1.DE is one of the better performing stocks in the market, outperforming 88.34% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to IX1.DE. IX1.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months IX1.DE reported a non-GAAP Earnings per Share(EPS) of 11.08. The EPS increased by 16.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.65% | ||
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| Debt/Equity | 0.53 |
22 analysts have analysed IX1.DE and the average price target is 692.16 EUR. This implies a price increase of 28.27% is expected in the next year compared to the current price of 539.6.
For the next year, analysts expect an EPS growth of 13.36% and a revenue growth 8.92% for IX1.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 16.51 | 111.035B | ||
| SHL | SIEMENS HEALTHINEERS AG | 17.45 | 46.699B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.32 | 23.91B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.29 | 23.871B | ||
| BIM | BIOMERIEUX | 18.94 | 11.221B | ||
| DIA | DIASORIN SPA | 17.97 | 4.111B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.68 | 3.894B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.66 | 2.461B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.82 | 1.619B | ||
| DRW8 | DRAEGERWERK AG | 9.59 | 1.313B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE US
Employees: 11000
Phone: 12075560300
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
The current stock price of IX1.DE is 539.6 EUR. The price increased by 0.52% in the last trading session.
IX1.DE does not pay a dividend.
IX1.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
22 analysts have analysed IX1.DE and the average price target is 692.16 EUR. This implies a price increase of 28.27% is expected in the next year compared to the current price of 539.6.
IDEXX LABORATORIES INC (IX1.DE) has a market capitalization of 43.09B EUR. This makes IX1.DE a Large Cap stock.
IDEXX LABORATORIES INC (IX1.DE) will report earnings on 2026-04-29, before the market open.